vHospital
Hormonal Contraceptive

Desogestrel: Mechanism of Action

Desogestrel is a hormonal agent used for contraception, hormone replacement therapy, or the management of menstrual and gynecological disorders.

MechanismInteractionsEvidenceClinical Studies

Hormonal contraceptives suppress ovulation and alter reproductive tract conditions through progestin and/or estrogen receptor actions.

How It Works

Hormonal contraceptives contain synthetic progestins (±ethinylestradiol) acting on the hypothalamic-pituitary-gonadal (HPG) axis. Progestins bind progesterone receptors (PR-A and PR-B), suppressing GnRH pulsatility → reduced LH and FSH secretion → ovulation suppression. Combined OCP also uses estrogen to suppress FSH-driven follicular development. Additional mechanisms: cervical mucus thickening (reducing sperm penetration), endometrial thinning (reducing implantation potential), and altered fallopian tube motility. Different progestins vary in receptor affinity: drospirenone is anti-androgenic with anti-mineralocorticoid activity; levonorgestrel has mild androgenic activity.

Receptor / Target Profile

Pharmacokinetics

Onset of Action

Ovulation suppression: within 7 days if initiated day 1–5 of cycle; cervical mucus changes within 48 hours

Half-Life (t½)

Ethinylestradiol: ~24 hours; Levonorgestrel: ~24 hours; Drospirenone: ~30 hours; Desogestrel (active metabolite etonogestrel): ~30 hours

Oral bioavailability: ethinylestradiol ~45%; levonorgestrel ~100%; drospirenone ~76%. Extensive first-pass hepatic metabolism. Enterohepatic recirculation of ethinylestradiol. Depot medroxyprogesterone (IM) provides 3-month contraception via slow release.

Conditions Treated with Desogestrel

Questions about your medication?

Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant medications.

Use AI Symptom Checker →